Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
BioXcel Therapeutics, Inc. (BTAI) had Weighted-Average Shares Outstanding (Basic) of 30.30M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.18M |
|
$-14.71M |
|
$0.02M |
|
$0.16M |
|
$10.38M |
|
$-10.19M |
|
$-4.52M |
|
$-14.71M |
|
$-14.71M |
|
$-14.71M |
|
$-14.71M |
|
$-14.71M |
|
$-14.71M |
|
$-10.19M |
|
$-10.18M |
|
|
Weighted-Average Shares Outstanding (Basic) |
30.30M |
30.30M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$28.70M |
|
$0.10M |
|
$0.10M |
|
$28.80M |
|
$137.15M |
|
-- |
|
$7.11M |
|
$144.26M |
|
$-115.46M |
|
$-115.46M |
|
$-115.46M |
|
31.30M |
|
| Cash Flow Statement Financials | |
$-17.91M |
|
-- |
|
$2.95M |
|
$28.76M |
|
$13.80M |
|
$-14.96M |
|
$0.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.21 |
|
-- |
|
-- |
|
-- |
|
-0.90 |
|
87.91% |
|
-5600.55% |
|
-5600.55% |
|
-- |
|
-8084.07% |
|
-8084.07% |
|
$-17.91M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.05 |
|
2.22 |
|
40.55 |
|
12.74% |
|
12.74% |
|
-51.09% |
|
12.74% |
|
$-3.69 |
|
$-0.59 |
|
$-0.59 |
|